Close

News

Clinerion received ISO 27001:2013 certification

Clinerion has gained ISO 27001:2013 certification, the international standard that describes best practice for an information security management system (ISMS). ISO 27001:2013 is a standard set by the International Organization for Standardization (ISO), the independent, non-governmental international organization of national...

COVID-19 and the pharma supply chain – How to manage your pharmaceutical logistics in difficult times

With panic buying of face masks and no hand sanitiser on chemists’ shelves, there is no doubt that the latest COVID-19 outbreak is having a global effect. Schools are closing, conferences and sporting events are being cancelled… it is...

Sinclair Research Announces Toxicology Laboratory Expansion

Sinclair Research, a leading provider of nonclinical contract research services, will officially open its 20,000-square-foot laboratory expansion later this spring. The additional capacity will support GLP nonclinical toxicology research studies to meet the growing demand from pharmaceutical customers for...

FDA Issues Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19

Thermo Fisher Scientific Inc., the world leader in serving science, announced that the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories...

BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat

BioNTech SE provides further details on the Company’s R&D effort, “Project Lightspeed”, to develop a potential vaccine to induce immunity and prevent COVID-19 infection in response to the growing global health threat posed by the disease. BioNTech’s product candidate,...

Nurix raises $120m financing to advance its protein modulation pipeline

San Francisco based-Nurix has closed its funding round with a total of $120m. The financing was led by Foresite Capital and supported by new investors Bain Capital Life Sciences, Boxer Capital, EcoR1 Capital, Redmile Group and Wellington Management Company....

Mallinckrodt Pharmaceuticals explores iNO as potential Covid-19 therapy

Mallinckrodt has started exploring inhaled nitric oxide (iNO) as a potential supportive measure for COVID-19 patients with pulmonary complications. The company partnered with the US Food and Drug Administration (FDA), the National Institutes of Health (NIH) and the Biomedical Advanced...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »